...
首页> 外文期刊>The Lancet infectious diseases >Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.
【24h】

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

机译:艰难梭菌PCR 027型核糖体:评估进一步在全球范围传播的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

Highly virulent strains of Clostridium difficile have emerged since 2003, causing large outbreaks of severe, often fatal, colitis in North America and Europe. In 2008-10, virulent strains spread between continents, with the first reported cases of fluoroquinolone-resistant C difficile PCR ribotype 027 in three Asia-Pacific countries and Central America. We present a risk assessment framework for assessing risks of further worldwide spread of this pathogen. This framework first requires identification of potential vehicles of introduction, including international transfers of hospital patients, international tourism and migration, and trade in livestock, associated commodities, and foodstuffs. It then calls for assessment of the risks of pathogen release, of exposure of individuals if release happens, and of resulting outbreaks. Health departments in countries unaffected by outbreaks should assess the risk of introduction or reintroduction of C difficile PCR ribotype 027 using a structured risk-assessment approach.
机译:自2003年以来,出现了高毒力的艰难梭菌菌株,在北美和欧洲引起了严重的,通常是致命的结肠炎大爆发。在2008-10年度,强毒株在各大洲之间传播,在三个亚太国家和中美洲首次报告了耐氟喹诺酮类难辨C难辨PCR核糖体027型。我们提出了一种风险评估框架,用于评估该病原体在全球范围内进一步传播的风险。该框架首先需要确定潜在的引进工具,包括医院患者的国际转移,国际旅游和移民以及牲畜,相关商品和食品的贸易。然后,它要求评估病原体释放的风险,如果发生释放则个体暴露的风险以及由此引起的暴发。不受疫情影响的国家/地区的卫生部门应使用结构化风险评估方法评估引入或重新引入艰难梭菌PCR核糖体027型的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号